Duane Nash

Duane D.
Nash is currently Director at Immunic, Inc. since 2026 and Member of the Supervisory Board at Immunic AG.
Former positions include President, Chief Executive Officer & Director at Vital Therapies, Inc. in 2019; Director at Aerpio Therapeutics LLC from 2012 to 2017; Independent Director at Akebia Therapeutics, Inc. from 2013 to 2018; Vice President at Wedbush Securities, Inc.; Attorney at Davis Polk & Wardwell LLP from 2002 to 2008; Research Analyst at Pacific Growth Equities, Inc.; and Senior Vice President-Equity Research at Wedbush Pacgrow Healthcare from 2009 to 2012.
Education includes an MBA from the University of Oxford in 2002, graduate studies at the University of California, Berkeley, an undergraduate degree from Williams College in 1993, and a doctorate from Dartmouth Medical School in 1997.